Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy.
about
Human immunodeficiency virus & cardiovascular riskNevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of AntiretroviralsUltrasound-assessed perirenal fat is related to increased ophthalmic artery resistance index in HIV-1 patients.Smoking cessation among women with and at risk for HIV: are they quitting?Cross-sectional study of unexplained white matter lesions in HIV positive individuals undergoing brain magnetic resonance imaging.Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosisHeart and HAART: Two sides of the coin for HIV-associated cardiology issuesHIV-associated lipodystrophy.Strategies for treating HIV-related lipodystrophy.Increasing incidence of ischemic stroke in patients with HIV infection.Evaluation and management of dyslipidemia in patients with HIV infection.Cigarette smoking in the HIV-infected population.Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular diseasePreclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study.Effect of inter-reader variability on outcomes in studies using carotid intima media thickness quantified by carotid ultrasonographyDyslipidemia and its Treatment in HIV Infection.Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART era.Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thicknessChronic depressive symptoms and Framingham coronary risk in HIV-infected and HIV-uninfected women.The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes MellitusNoninvasive assessment of arterial stiffness and risk of atherosclerotic events in children.Treatment of dyslipidaemia in HIV-infected persons.Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity.Platelet decline as a predictor of brain injury in HIV infection.Cardiovascular disease in HIV infection.Benefits of leptin therapy in HIV patients.Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort.Antiretroviral therapy and the human immunodeficiency virus--improved survival but at what cost?Ultrasound measurements of carotid intima-media thickness and plaque in HIV-infected patients on the Mediterranean diet.Prevention of atherosclerosis in patients living with HIV.HIV-1 antiretrovirals induce oxidant injury and increase intima-media thickness in an atherogenic mouse model.Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitutionEpidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy.Stroke in HIV infection and AIDS.Noninvasive assessment of HIV-related coronary artery disease.How to address smoking cessation in HIV patients.Case Series of HIV Infection-Associated Arteriopathy: Diagnosis, Management, and Outcome Over a 5-Year period at Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University.
P2860
Q22241184-6B96F612-FD61-4B0B-902F-13E2623C240AQ24802369-897C0B06-2502-4F75-8651-1B32CE1BA064Q28069383-BF5A350E-8F21-4474-90B8-730B2DA3D9F4Q30480466-20D0B461-8746-4FD7-AA3B-8C84DE8DA4AEQ33611409-2BF0497A-8CB0-4EC5-96C0-5A8E6FB4DBD3Q33820078-0E1613D5-7E82-46C4-8816-5D4523FBD0C9Q33942966-195442AE-6FA8-485C-856F-F06B5CBBE644Q34390565-4AFC5DFC-B050-41C1-91C5-BF4CE40A187AQ34459421-A7B83BE0-3312-47D9-B88F-64C4404BCE2FQ34481623-263B6FC4-434A-422C-A68C-ECABBC5EAE2EQ34555429-110053AC-28DA-4DDD-900B-BC7C066D7010Q34743413-A898AD12-A0B1-4B95-B233-6D520839F989Q35095054-5AD5302F-2AEA-4350-9A1C-DDC0796894D1Q35104006-6C5A8BB7-BC1A-45D9-A3B7-4B1B76461D95Q35166149-A3DCC4AD-DE58-4D63-A331-2F4D966E8591Q35179406-08372426-B228-46C4-8273-BEA99C3B81CBQ35293841-E5EA5815-941B-4A39-AF15-17FC90DE4CE1Q35370152-1D71278E-E42A-4E1F-8C5E-7C70C11F53B5Q35492436-43BF3A09-DA88-4B10-AD17-89A1FB57661BQ35574115-562EF717-DE1A-409F-9495-867DFA440E68Q35627037-85B4036B-1376-4EA0-9C90-C7612E1FC970Q35730973-54C68AE9-F188-4A36-A940-7D163C5204FAQ36213733-684439ED-6938-4D4C-B965-943D2EC26BC0Q36222023-7A4D700D-B551-453D-A6FA-8365C7E54C32Q36287967-135E5642-A7D3-467B-B78E-86E31A0FF21DQ36320562-E288BE5D-8F39-4959-97A0-47D573F0C21CQ36408675-42CCFB5A-5FB5-4FCD-B5A8-AF097EFB1643Q36700922-6998D417-6127-424C-BDBE-2B84AC4F5A59Q36914867-6B33EE68-4F4D-4D5F-BF3D-0F69350E3462Q36933854-4A771290-1736-49A5-808D-B049CC46376DQ37147740-64B73AD1-558C-47CC-ACA0-69507D4F46A4Q37167541-1B44BECD-3554-4096-AC61-63A0BF7DC760Q37188672-8994480D-EE67-46B1-9839-F06C51184DE2Q37350467-EB7F8F90-32F7-497E-965A-3FC02D68B15AQ37423288-A09F0FF0-A341-4EB5-BD0E-333A3AE4942EQ37496608-80BAA5C2-03EF-4F42-BB46-DADC8F52D663Q37611052-5A3E423B-F65C-4B4F-BE63-F3B0BF46B27AQ37846118-1B8C8E4C-0F7C-4483-8176-742C7E7F97A8Q38258200-D8591E37-C755-421C-8E25-8048B33EAD11Q38564800-5ECE93BB-7457-4EAB-909A-2A6699E45AC1
P2860
Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Premature atherosclerosis in H ...... on protease inhibitor therapy.
@en
Premature atherosclerosis in H ...... on protease inhibitor therapy.
@nl
type
label
Premature atherosclerosis in H ...... on protease inhibitor therapy.
@en
Premature atherosclerosis in H ...... on protease inhibitor therapy.
@nl
prefLabel
Premature atherosclerosis in H ...... on protease inhibitor therapy.
@en
Premature atherosclerosis in H ...... on protease inhibitor therapy.
@nl
P2093
P1433
P1476
Premature atherosclerosis in H ...... on protease inhibitor therapy.
@en
P2093
M Depairon
P304
P356
10.1097/00002030-200102160-00005
P407
P577
2001-02-01T00:00:00Z